Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05739201
Other study ID # 36264MS18/1/23
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 20, 2023
Est. completion date December 20, 2023

Study information

Verified date September 2023
Source Tanta University
Contact Shrouk M Elsawaf, Master
Phone +201091533902
Email Shroukms95@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to investigate the post-operative analgesic effect of interscalene nerve block or anterior suprascapular nerve block compared to pericapsular nerve group block in patient undergoing elective arthroscopic shoulder surgery.


Description:

Shoulder arthroscopy is a common outpatient operation with an increasing number of indications and complexity. Early postoperative pain immediately following shoulder surgery is a major concern and cause of distress for patients and orthopedic surgeons. Adequate pain control is vital for all aspects of the patient's recovery. Nowadays, several ultrasound -guided regional anesthesia methods are used for postoperative analgesia. Regional techniques such as interscalene and supraclavicular blocks are usually preferred for shoulder analgesia. Interscalene brachial plexus block (ISB) is the gold standard technique in this area. Suprascapular nerve block (SSB) has been proposed as an alternative to the ISB in providing analgesia for shoulder surgeries as it has a lower likelihood of causing phrenic nerve blockade. The pericapsular nerve group (PENG) block has been suggested to be safely applied for analgesia and can be part of surgical anesthesia, but alone is not sufficient for anesthesia in shoulder surgery. The block of this area did not cause motor block or pulmonary complications, nor result in muscle laxity, blocking only the shoulder and the upper third of the humerus.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 20, 2023
Est. primary completion date December 20, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Adult patients. - ASA class I and II and scheduled for elective shoulder arthroscopy. Exclusion Criteria: - Patient who refuses the regional anesthesia technique. - History of allergy to local anesthetics. - Local infection at the site of the block. - History of Pre-existing major organ dysfunction such as hepatic and renal failure. - History of pre-existing lung disease (COPD, uncontrolled asthma). - Preexisting upper extremity neurological abnormality or neuropathy. - Difficulties in comprehending (NRS). - Chronic opioid users (opioid intake more than 3 months).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
interscalene nerve block
Patients will receive interscalene nerve block, in which the patient will be in supine position with the head turned to the contralateral side using an ultrasound scan to identify the C5 and C6 nerve roots between the scalene muscles.15 ml of 0.25% Bupivacaine will be deposited between the C5 and C6 nerve roots, within the interscalene groove using a 22 gauge-regional block needle.
anterior suprascapular nerve block
Patients will receive anterior suprascapular nerve block, in which the patient will be in supine position with the head turned to the contralateral side, using an ultrasound the nerve will be traced as it diverges from the brachial plexus to lie under the omohyoid muscle in the supraclavicular fossa. 15 ml of 0.25% Bupivacaine will be deposited lateral to the suprascapular nerve, underneath the omohyoid muscle using a 22 gauge-regional block needle.
Peri-capsular nerve group block
Patients will receive PENG block, in which the patient will be in supine position and the patient's arm will be placed in external rotation and abducted at 45 degrees, using an ultrasound the humeral head, the tendon of the subscapularis muscle and the deltoid muscle over it will be defined, 15 ml of 0.25% Bupivacaine will be placed between the deltoid muscle and subscapularis tendon using a 22 gauge-regional block needle.

Locations

Country Name City State
Egypt Shrouk Mohamed Elsawaf Tanta EL-Gharbia

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary the total opioid consumption. Postoperative analgesia will be assessed by total opioid consumption and time till administration of first rescue analgesia will be recorded. 24-hour postoperatively
See also
  Status Clinical Trial Phase
Completed NCT04101266 - Pain Management in Arthtroscopic Shoulder Surgery N/A
Not yet recruiting NCT04152135 - Hemodynamic Changes With Passive Leg Raising Maneuver in Patients Undergoing Arthroscopic Shoulder Surgery
Terminated NCT02867904 - Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery Phase 4
Completed NCT01351363 - Prediction Of Post Operative Pain Following Arthroscopic Shoulder Surgery N/A
Completed NCT03691922 - Erector Spinae Block Versus Shoulder Periarticular Anesthetic Infiltration for Arthroscopic Shoulder Surgery N/A
Not yet recruiting NCT03602469 - Postoperative Analgesia of Magnesium Sulfate in Suprascapular Nerve Block Following Shoulder Arthroscopy N/A
Not yet recruiting NCT03738735 - Randomized, Controlled Trial of Hyperosmotlar Saline for Rotator Cuff Repair Irrigation Solution Phase 4
Terminated NCT04633837 - Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery N/A
Completed NCT04669639 - A Comparison of ESP Block to SSN Block for Analgesia in Shoulder Surgery N/A
Active, not recruiting NCT04675671 - Analgesic and Anxiety Efficacy of Preemptive Pregabalin
Completed NCT03277326 - Interscalene vs Anterior and Posterior Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries N/A
Recruiting NCT00731146 - Effects of Technique on the Local Anesthetic Dose Required for Interscalene Brachial Plexus Block N/A
Completed NCT03212443 - Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery N/A